We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
EMA: Reduce Colistin Use in Animals
News

EMA: Reduce Colistin Use in Animals

EMA: Reduce Colistin Use in Animals
News

EMA: Reduce Colistin Use in Animals

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "EMA: Reduce Colistin Use in Animals"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

news_colistin.jpg

The European Medicines Agency (EMA) has updated its 2013 scientific advice on the use in animals of the antibiotic colistin.

The new advice was requested by the European Commission following the discovery of a new mechanism of resistance in bacteria to colistin (caused by the mcr-1 gene), with the potential to spread rapidly.

EFSA contributed to the work of its sister agency by providing data submitted by EU Member States on the occurrence of resistance to colistin in E. coli and Salmonella from food and food-producing animals, taking part in meetings of the working group, and contributing to scientific discussions.

EMA experts advise Member States to minimise sales of colistin for use in animals, and that colistin be used only to treat clinical conditions for which there are no effective alternative treatments.

Advertisement